PT  - JOURNAL ARTICLE
AU  - Hatton, Courtney L.
AU  - Davis, Brittany N.
AU  - Jama, Mahamed A.
AU  - Samdani, Nidha S.
TI  - The Relationship Between Treatment Center Services and Number of Opioid-related Deaths in the United States Before and After a Declaration of a National Opioid Crisis
AID  - 10.1101/2022.10.03.22280663
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.10.03.22280663
4099  - http://medrxiv.org/content/early/2022/10/05/2022.10.03.22280663.short
4100  - http://medrxiv.org/content/early/2022/10/05/2022.10.03.22280663.full
AB  - Opioid-related deaths are a national problem that have increased over the past two decades. Multiple policy interventions have been enacted to decrease opioid misuse and expand treatment. The Comprehensive Addiction and Recovery Act (CARA) was passed in July 2016, just before declaring the opioid epidemic a National Emergency in 2017. CARA was enacted to combat the opioid epidemic by providing more funding yearly for items including but not limited to prevention, treatment, and opioid overdose reversal. To evaluate the impact of these policy changes, we carried out secondary data analysis for the period 2011-2019 using the CDC’s Wide-ranging Online Data for Epidemiologic Research and National Survey of Substance Abuse Treatment Services databases.Research variables included: a comparison of the 50 states across the 2011-2019 timeframe, the number of opioid treatment centers, the percentage of government funding for facilities per state, percentage of opioid treatment facilities which offer free/low-income services and the opioid death rate. We also assessed differences in low-income access to opioid treatment services by comparing Medicaid expansion states versus non-Medicaid expansion states.While both the number of treatment facilities per state and opioid death rates nearly doubled during this time, there was little to no association between them (R2 ranging from: 0.094-0.188 for years 2013-2019). Our research suggests that while state-level differences in opioid use disorder treatment facility characteristics related to access to care, they were only weakly associated with opioid-related deaths. This analysis may be used in the planning of subsequent actions against the national opioid epidemic and invites further inquiry into the impact of state Medicaid expansion on drug-specific opioid usage and mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Geisinger Commonwealth School of Medicine gave ethical approval for this work, approval #2021-0794.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. http://wonder.cdc.gov/ucd-icd10.html https://www.datafiles.samhsa.gov/study-series/national-survey-substance-abuse-treatment-services-n-ssats-nid13519